Maintenance therapy for myeloma can be stopped after two years without raising the risk of disease progression or death,…
Articles by Marisa Horak, MS
An anticancer vaccine targeting a common genetic driver of pancreatic cancer was shown to be safe in an early…
Dosing has begun in a Phase 3 clinical trial testing whether the antibody therapy Gamunex-C (immune globulin injection [human], 10%…
Combining immunotherapy with an experimental cell therapy from Ernexa Therapeutics completely eliminated ovarian cancer in two-thirds of mice in…
The U.S. Food and Drug Administration (FDA) has set a date for next year by which it will decide whether…
July 15 marks the eighth annual Glioblastoma Awareness Day in the U.S., and advocates are calling for continued efforts to…
The U.S. Food and Drug Administration (FDA) has approved a new version of Sarclisa (isatuximab), an approved treatment for…
The U.S. Food and Drug Administration (FDA) has approved a new cell-based therapy designed to help restore the immune system…
Regulatory authorities in two countries have given the green light for clinical testing of a novel treatment from Mabwell…
A new arm of a clinical trial has begun testing Knoa Pharma‘s experimental therapy tinostamustine in people with glioblastoma,…